U.S. District Court Decides That Isolated Genes Cannot Be Patented

April 01, 2010

Tags:

Advertising and Marketing Intellectual Property Intellectual Property Litigation Life Sciences Patents

Related Expertise

Related Insights

Video: how will the Federal Court’s ruling on changes to the Patented Medicines Regulations impact the pharmaceutical industry?
Déjà vu: PMPRB asserts jurisdiction over Galderma’s drug, Differin
Federal Court on amended Patented Medicines Regulations: new pricing factors and new basket of comparison countries are in; rebate reporting is out
Delay in Canada’s drug pricing reforms to 2021
Pause on PMPRB reform: implementation of new pricing regulations delayed to 2021

Back